Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    18497327 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Temozolomide Plus Lomustine Followed by Radiation Therapy in Treating Patients With High-Grade Malignant Glioma
Conditions: Brain Tumor;   Central Nervous System Tumor
Interventions: Drug: lomustine;   Drug: temozolomide

Indicates status has not been verified in more than two years